HeyJaredACRO Podcast
The ACRO Podcast is developed by the nation's leading radiation oncologists and is designed to provide clinicians and program leaders with critically important clinical, business, and advocacy content to advance cancer care and the careers of those professionals we represent.
- Indexed episodes, last 90 days
- 4
- Latest publication
- Sep 28, 2026
- Audience
- Checking…
- Earliest in this view
- Jul 30, 2026
Latest episodes
Radiate Insights Lung Cancer Roundtable: Importance of the MDT (opens the original)
Read excerpt
A panel of experts, led by Dr. Brian Lally, president of ACRO, discusses the importance of the multidisciplinary team.
Radiate Insights Lung Cancer Roundtable: Treatment Complexities (opens the original)
Read excerpt
A panel of experts, led by Dr. Brian Lally, president of ACRO, discusses current challenges in the treatment of lung cancer with systemic and radiation therapy.
Reimbursement Matters: 2027 Medicare Rules & Evolving Coverage Issues (opens the original)
Read excerpt
In the first episode of Reimbursement Matters, ACRO’s Dr. Jared Pasetsky and Teri Bedard from RCCS discuss three timely reimbursement and coverage issues affecting radiation oncology. The conversation covers the 2027 proposed Medicare rules, evolving coverage for radiation therapy used to treat benign disease and recent claims challenges affecting radiation oncology practices. They break down what’s changing, what practices should be watching and practical steps to consider in the months ahead.
CURiE Conversations: Small-Cell Carcinoma of the Bladder With Concurrent High-Grade Prostate Cancer: A Case Report and Review of the Literature (opens the original)
Read excerpt
In this episode of CURiE Conversations, host Dr. Jessica Schuster speaks with Dr. Veronia Fahmy and Dr. James S. Welsh about their published work, "Small-Cell Carcinoma of the Bladder With Concurrent High-Grade Prostate Cancer: A Case Report and Review of the Literature."The discussion explores the management of this rare synchronous malignancy, the rationale for bladder-preserving chemoradiotherapy, the role of hypofractionated radiation and the clinical decision to use MRI surveillance instead
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Not enough subject data for this period yet.
Audience
No verified audience measurement yet.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.